keyword
https://read.qxmd.com/read/38630581/protein-engineering-with-lightweight-graph-denoising-neural-networks
#1
JOURNAL ARTICLE
Bingxin Zhou, Lirong Zheng, Banghao Wu, Yang Tan, Outongyi Lv, Kai Yi, Guisheng Fan, Liang Hong
Protein engineering faces challenges in finding optimal mutants from a massive pool of candidate mutants. In this study, we introduce a deep-learning-based data-efficient fitness prediction tool to steer protein engineering. Our methodology establishes a lightweight graph neural network scheme for protein structures, which efficiently analyzes the microenvironment of amino acids in wild-type proteins and reconstructs the distribution of the amino acid sequences that are more likely to pass natural selection...
April 17, 2024: Journal of Chemical Information and Modeling
https://read.qxmd.com/read/38629737/strategies-to-improve-cho-cell-culture-performance-targeted-deletion-of-amino-acid-catabolism-and-apoptosis-genes-paired-with-growth-inhibitor-supplementation
#2
JOURNAL ARTICLE
Cynthia Lam, Alyssa Sargon, Camil Diaz, Zijuan Lai, Dewakar Sangaraju, Inn Yuk, Gavin Barnard, Shahram Misaghi
Chinese hamster ovary (CHO) cells are the predominant host of choice for recombinant monoclonal antibody (mAb) expression. Recent advancements in gene editing technology have enabled engineering new CHO hosts with higher growth, viability, or productivity. One approach involved knock out (KO) of BCAT1 gene, which codes for the first enzyme in the branched chain amino acid (BCAA) catabolism pathway; BCAT1 KO reduced accumulation of growth inhibitory short chain fatty acid (SCFA) byproducts and improved culture growth and titer when used in conjunction with high-end pH-controlled delivery of glucose (HiPDOG) technology and SCFA supplementation during production...
April 17, 2024: Biotechnology Progress
https://read.qxmd.com/read/38628551/a-novel-approach-to-designing-viral-precision-vaccines-applied-to-sars-cov-2
#3
JOURNAL ARTICLE
Khaled Trabelsi, Noureddin Ben Khalaf, Ahmed R Ramadan, Amany Elsharkawy, Dana Ashoor, Sadok Chlif, Thouraya Boussoffara, Melika Ben-Ahmed, Mukesh Kumar, M-Dahmani Fathallah
Efficient precision vaccines against several highly pathogenic zoonotic viruses are currently lacking. Proteolytic activation is instrumental for a number of these viruses to gain host-cell entry and develop infectivity. For SARS-CoV-2, this process is enhanced by the insertion of a furin cleavage site at the junction of the spike protein S1/S2 subunits upstream of the metalloprotease TMPRSS2 common proteolytic site. Here, we describe a new approach based on specific epitopes selection from the region involved in proteolytic activation and infectivity for the engineering of precision candidate vaccinating antigens...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38627328/studies-on-treatment-within-the-scope-of-medical-biotechnology-for-pancreatic-diseases
#4
REVIEW
Dilara Aylar, Ayse Karatug Kacar
The pancreas is made of two compartments: the exocrine pancreas, a source of digestive enzymes, and the endocrine islets which produce vital hormones. Distinct diseases could arise in the pancreas such as diabetes, neuroendocrine tumors, pancreatitis, and pancreatic cancers. Various treatment methods are being researched against these diseases. Treatment with recombinant proteins, therapeutic antibodies, vaccination, gene therapy, tissue engineering, and stem cell treatment are treatment methods. Furthermore, biomarkers are important for both treatment and diagnosis...
April 16, 2024: Molecular Biotechnology
https://read.qxmd.com/read/38626556/the-orientation-of-cpg-conjugation-on-aluminum-oxyhydroxide-nanoparticles-determines-the-immunostimulatory-effects-of-combination-adjuvants
#5
JOURNAL ARTICLE
Zhihui Liang, Hang Bao, Zhiying Yao, Min Li, Chen Chen, Lei Zhang, Huiyang Wang, Yiyang Guo, Yubin Ma, Xuecheng Yang, Ge Yu, Jiancheng Zhang, Changying Xue, Bingbing Sun, Chuanbin Mao
In subunit vaccines, aluminum salts (Alum) are commonly used as adjuvants, but with limited cellular immune responses. To overcome this limitation, CpG oligodeoxynucleotides (ODNs) have been used in combination with Alum. However, current combined usage of Alum and CpG is limited to linear mixtures, and the underlying interaction mechanism between CpG and Alum is not well understood. Thus, we propose to chemically conjugate Alum nanoparticles and CpG (with 5' or 3' end exposed) to design combination adjuvants...
April 11, 2024: Biomaterials
https://read.qxmd.com/read/38624000/self-assembled-recombinant-elastin-and-globular-protein-vesicles-with-tunable-properties-for-diverse-applications
#6
JOURNAL ARTICLE
Mikaela A Gray, Mariela R Rodriguez-Otero, Julie A Champion
ConspectusVesicles are self-assembled structures comprised of a membrane-like exterior surrounding a hollow lumen with applications in drug delivery, artificial cells, and micro-bioreactors. Lipid or polymer vesicles are the most common and are made of lipids or polymers, respectively. They are highly useful structures for many applications but it can be challenging to decorate them with proteins or encapsulate proteins in them, owing to the use of organic solvent in their formation and the large size of proteins relative to lipid or polymer molecules...
April 16, 2024: Accounts of Chemical Research
https://read.qxmd.com/read/38622266/chromatography-affinity-resin-with-photosynthetically-sourced-protein-a-ligand
#7
JOURNAL ARTICLE
Nisha A Owens, Pieter H Anborgh, Igor Kolotilin
Green, photosynthesizing plants can be proficiently used as cost-effective, single-use, fully biodegradable bioreactors for environmentally-friendly production of a variety of valuable recombinant proteins. Being near-infinitely scalable and most energy-efficient in generating biomass, plants represent profoundly valid alternatives to conventionally used stationary fermenters. To validate this, we produced a plastome-engineered tobacco bioreactor line expressing a recombinant variant of the protein A from Staphylococcus aureus, an affinity ligand widely useful in antibody purification processes, reaching accumulation levels up to ~ 250 mg per 1 kg of fresh leaf biomass...
April 15, 2024: Scientific Reports
https://read.qxmd.com/read/38620013/aptashield-a-universal-signal-transduction-system-for-fast-and-high-throughput-optical-molecular-biosensing
#8
JOURNAL ARTICLE
Miguel António Dias Neves, Inês Mendes Pinto
Biosensing technologies are often described to provide facile, sensitive, and minimally to noninvasive detection of molecular analytes across diverse scientific, environmental, and clinical diagnostic disciplines. However, commercialization has been very limited mostly due to the difficulty of biosensor reconfiguration for different analyte(s) and limited high-throughput capabilities. The immobilization of different biomolecular probes (e.g., antibodies, peptides, and aptamers) requires the sensor surface chemistry to be tailored to provide optimal probe coupling, orientation, and passivation and prevent nonspecific interactions...
April 15, 2024: ACS Sensors
https://read.qxmd.com/read/38618507/the-role-of-biotechnology-in-latest-therapeutic-approaches-for-diabetes-mellitus
#9
EDITORIAL
Sepideh Hajivalizadeh, Shahin Akhondzadeh
No abstract text is available yet for this article.
2024: Avicenna Journal of Medical Biotechnology
https://read.qxmd.com/read/38617793/improving-the-pharmacokinetics-biodistribution-and-plasma-stability-of-monobodies
#10
JOURNAL ARTICLE
Adrian Valentin Dinh-Fricke, Oliver Hantschel
Cancer is a leading cause of death worldwide. Several targeted anticancer drugs entered clinical practice and improved survival of cancer patients with selected tumor types, but therapy resistance and metastatic disease remains a challenge. A major class of targeted anticancer drugs are therapeutic antibodies, but their use is limited to extracellular targets. Hence, alternative binding scaffolds have been investigated for intracellular use and better tumor tissue penetration. Among those, monobodies are small synthetic protein binders that were engineered to bind with high affinity and selectivity to central intracellular oncoproteins and inhibit their signaling...
April 4, 2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38612744/meeting-the-challenge-of-controlling-viral-immunopathology
#11
REVIEW
Engin Berber, Sachin Mulik, Barry T Rouse
The mission of this review is to identify immune-damaging participants involved in antiviral immunoinflammatory lesions. We argue these could be targeted and their activity changed selectively by maneuvers that, at the same time, may not diminish the impact of components that help resolve lesions. Ideally, we need to identify therapeutic approaches that can reverse ongoing lesions that lack unwanted side effects and are affordable to use. By understanding the delicate balance between immune responses that cause tissue damage and those that aid in resolution, novel strategies can be developed to target detrimental immune components while preserving the beneficial ones...
April 1, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612450/preparation-of-bispecific-igy-scfvs-inhibition-adherences-of-enterotoxigenic-escherichia-coli-k88-and-f18-to-porcine-ipec-j2-cell
#12
JOURNAL ARTICLE
Luqing Yang, Yuanhe Yang, Anguo Liu, Siqi Lei, Pingli He
Enterotoxigenic Escherichia coli (ETEC) strains are significant contributors to postweaning diarrhea in piglets. Of the ETEC causing diarrhea, K88 and F18 accounted for 92.7%. Despite the prevalence of ETEC K88 and F18, there is currently no effective vaccine available due to the diversity of these strains. This study presents an innovative approach by isolating chicken-derived single-chain variable fragment antibodies (scFvs) specific to K88 and F18 fimbrial antigens from chickens immunized against these ETEC virulence factors...
March 25, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38607601/neutralizing-anti-diphtheria-toxin-scfv-produced-by-phage-display
#13
JOURNAL ARTICLE
Ehsan Khalili, Mostafa Lakzaei, Mahdi Aminian
BACKGROUND: Diphtheria can be prevented by vaccination, but some epidemics occur in several places, and diphtheria's threat is considerable. Administration of diphtheria antitoxin (DAT) produced from hyperimmunized animals is the most common treatment. Recombinant human antibody fragments such as single-chain variable fragments (scFv) produced by phage display library may introduce an interesting approach to overcome the limitations of the traditional antibody therapy. In the present study, B cells of immunized volunteers were used to construct a human single-chain fragment (HuscFv) library...
April 12, 2024: Biotechnology Letters
https://read.qxmd.com/read/38607316/a-systemic-approach-to-identifying-sequence-frameworks-that-decrease-mab-production-in-a-transient-chinese-hamster-ovary-cell-expression-system
#14
JOURNAL ARTICLE
Alana C Szkodny, Kelvin H Lee
Monoclonal antibodies (mAbs) are often engineered at the sequence level for improved clinical performance yet are rarely evaluated prior to candidate selection for their "developability" characteristics, namely expression, which can necessitate additional resource investments to improve the manufacturing processes for problematic mAbs. A strong relationship between primary sequence and expression has emerged, with slight differences in amino acid sequence resulting in titers differing by up to an order of magnitude...
April 12, 2024: Biotechnology Progress
https://read.qxmd.com/read/38606717/functional-properties-and-skin-care-effects-of-sodium-trehalose-sulfate
#15
JOURNAL ARTICLE
Kazuhisa Maeda, Zheng Zhou, Miao Guo, Jinlong Zhang, Lang Chen, Fan Yang
BACKGROUND: It is known that heparinoid, a mucopolysaccharide polysulfate, is effective in improving rough skin and promoting blood circulation as medicines for diseased areas. However, heparinoid has a molecular weight of more than 5000 and cannot penetrate healthy stratum corneum. OBJECTIVE: We tested the efficacy of sulfated oligosaccharides with a molecular weight of less than 2000 on the human skin barrier function and moisturizing function. METHODS: We measured the transepidermal water loss (TEWL) of a three-dimensional human epidermis model cultured for 3 days after topical application of sulfated oligosaccharides, then observed the effects on TEWL suppression...
April 2024: Skin Research and Technology
https://read.qxmd.com/read/38605965/modular-design-of-bi-and-multi-specific-knob-domain-fusions
#16
JOURNAL ARTICLE
Mikhail Kuravsky, Glyn F Gibbons, Callum Joyce, Anthony Scott-Tucker, Alex Macpherson, Alastair D G Lawson
INTRODUCTION: The therapeutic potential of bispecific antibodies is becoming widely recognised, with over a hundred formats already described. For many applications, enhanced tissue penetration is sought, so bispecifics with low molecular weight may offer a route to enhanced potency. Here we report the design of bi- and tri-specific antibody-based constructs with molecular weights as low as 14.5 and 22 kDa respectively. METHODS: Autonomous bovine ultra-long CDR H3 (knob domain peptide) modules have been engineered with artificial coiled-coil stalks derived from Sin Nombre orthohantavirus nucleocapsid protein and human Beclin-1, and joined in series to produce bi- and tri-specific antibody-based constructs with exceptionally low molecular weights...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38604879/tailor-made-molecular-imprints-for-biological-event-intervention
#17
REVIEW
Fan Ding, Yue Ma, Wensi Fan, Jingjing Xu, Guoqing Pan
Molecular imprints, which are crosslinked architectures containing specific molecular recognition cavities for targeting compounds, have recently transitioned from in vitro diagnosis to in vivo treatment. In current application scenarios, it has become an important topic to create new biomolecular recognition pathways through molecular imprinting, thereby inhibiting the pathogenesis and regulating the development of diseases. This review starts with a pathological analysis, mainly focusing on the corresponding artificial enzymes, enzyme inhibitors and antibody mimics with enhanced functions that are created by molecular imprinting strategies...
April 10, 2024: Trends in Biotechnology
https://read.qxmd.com/read/38602218/fabrication-of-pegylated-spions-loaded-niosome-for-codelivery-of-paclitaxel-and-trastuzumab-for-breast-cancer-treatment-in-vivo-study
#18
JOURNAL ARTICLE
Saeideh Masoumi Godgaz, Azadeh Asefnejad, S Hajir Bahrami
There is a growing appeal for engineering drug delivery systems for controlled and local drug delivery. Conjugation of antibodies on the nanocarriers for targeted chemotherapeutic drugs has always been one of the main techniques. This work aims to develop a polycaprolactone/chitosan electrospun mat incorporated with paclitaxel/Fe3 O4 -loaded niosomes (SPNs) decorated with trastuzumab (TbNs) for cancer therapy. SPNs and TbNs were analyzed by DLS, zeta potential, scanning electron microscopy, transmission electron microscopy, and Fourier transform infrared spectroscopy...
April 11, 2024: ACS Applied Bio Materials
https://read.qxmd.com/read/38600786/effect-of-poly-ethylene-glycol-configuration-on-microbubble-pharmacokinetics
#19
JOURNAL ARTICLE
J Angel Navarro-Becerra, Jair I Castillo, Mark A Borden
Microbubbles (MBs) hold substantial promise for medical imaging and therapy; nonetheless, knowledge gaps persist between composition, structure, and in vivo performance, especially with respect to pharmacokinetics. Of particular interest is the role of the poly(ethylene glycol) (PEG) layer, which is thought to shield the MB against opsonization and rapid clearance but is also known to cause an antibody response upon multiple injections. The goal of this study was, therefore, to elucidate the role of the PEG layer in circulation persistence of MBs in the naïve animal (prior to an adaptive immune response)...
April 10, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38598902/a-novel-mica-b-targeted-chimeric-antigen-receptor-augments-the-cytotoxicity-of-nk-cells-against-tumor-cells
#20
JOURNAL ARTICLE
Changjiang Guo, Meng Dong, Xiang Wang, Jie Yu, Xinru Jin, Shizhuang Cheng, Feiyan Cui, Yifan Qian, Qianqian Bao, Lingtong Zhi, Zhiyuan Niu, Mingfeng Li, Wuling Zhu
Chimeric antigen receptor (CAR)-modified immune cells have emerged as a promising approach for cancer treatment, but single-target CAR therapy in solid tumors is limited by immune escape caused by tumor antigen heterogeneity and shedding. Natural killer group 2D (NKG2D) is an activating receptor expressed in human NK cells, and its ligands, such as MICA and MICB (MICA/B), are widely expressed in malignant cells and typically absent from healthy tissue. NKG2D plays an important role in anti-tumor immunity, recognizing tumor cells and initiating an anti-tumor response...
April 7, 2024: Biochemical and Biophysical Research Communications
keyword
keyword
42946
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.